Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed full pipeline small index

Cervical Ripening: full-pipeline trial registry

A small indexed set (9 trials) with no open enrollment listed right now.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · none currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cervical Ripening: 9 US clinical trials tracked, none currently recruiting.

Cervical Ripening is the subject of 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Ferring Pharmaceuticals, running 4 of these trials.

Enrollment posture brief

Registry condition cervical-ripening

OPEN 0 | RECR 0% | LATE 3 | EARLY 3 | RANK #1916 | SPON 4

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%Cervical Ripening (this)0%
Open-enrollment share among volume-matched conditions near Cervical Ripening

Cervical Ripening has no open enrollment in this registry pull (9 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cervical Ripening on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cervical Ripening is recruiting below its size-band peers.

    0 of 9 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cervical Ripening research.

    Ferring Pharmaceuticals accounts for 4 of 9 trials (44.4%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cervical Ripening enrolment sits around 180 participants.

    Median target enrolment is 180 among the 9 trials that report a genuine target (sentinel values excluded). 2 of those (22.2%) plan for fewer than 100 participants.

  4. Cervical Ripening research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 33

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED Phase 3 1,358 participants

Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery

Ferring Pharmaceuticals

NCT01127581

COMPLETED Phase 3 1,308 participants

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

Ferring Pharmaceuticals

NCT00308711

COMPLETED Phase 2 374 participants

Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor

Ferring Pharmaceuticals

NCT00828711

COMPLETED NA 197 participants

Foley Bulb Traction for Cervical Ripening

MetroHealth Medical Center

NCT00976703

COMPLETED Phase 3 180 participants

Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin

University Hospitals Cleveland Medical Center

NCT03138252

COMPLETED Phase 2 130 participants

Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation

University of Florida

NCT00325026

COMPLETED NA 100 participants

Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening

University of Oklahoma

NCT03111316

COMPLETED NA 94 participants

Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor

MemorialCare Health System

NCT02975167

COMPLETED Phase 2 24 participants

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Ferring Pharmaceuticals

NCT01283022

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 3

Named interventions

Most-linked intervention names on Cervical Ripening records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

MVI 200 Drug
3 trials
leg taping Other
1 trials
weighted bag Other
1 trials
Dinoprostone vaginal insert (Cervidil) Drug
1 trials
Misoprostol vaginal insert 50 mcg Drug
1 trials
Misoprostol vaginal insert 100 mcg Drug
1 trials
MVI 150 Drug
1 trials
MVI 100 Drug
1 trials

US sites by state

Facility locations filed on Cervical Ripening trials. A trial with sites in several states counts in each.

California 5 trials
New Mexico 3 trials
Florida 3 trials
Arizona 3 trials
Ohio 2 trials
New Jersey 2 trials
North Carolina 2 trials
Michigan 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cervical Ripening page

9 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Cervical Ripening trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Ferring Pharmaceuticals sponsors the most Cervical Ripening trials on record, review their full trial history before evaluating a specific study. See Ferring Pharmaceuticals's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cervical Ripening condition card totals 9 registered trials; most-linked intervention MVI 200; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.